Home › SEC Filings › Press Releases
Press Releases
All Current Report (8-K)Annual Report (10-K)Quarterly Report (10-Q)Form 4 Insider TradesSC 13D Beneficial Ownership13F Institutional HoldingsPress ReleasesInsider Cluster ActivityInsider Buy Activity
Theme?
All themes Artificial IntelligenceSemiconductorsQuantum ComputingSpace & SatellitesRobotics & AutomationElectric VehiclesClean & Renewable EnergyBattery & Energy StorageNuclear & FusionCybersecurityCloud & SaaSFintech & PaymentsCrypto & BlockchainGenomics & Gene EditingBiotech & Drug DiscoveryE-commerce & PlatformsStreaming & Digital MediaGaming & EsportsDefense TechCannabis
| Ticker | Type | Sentiment | Impact | Summary | Date |
|---|---|---|---|---|---|
| RDNW | PRESS-RELEASE | mixed | 5/10 | RideNow Group reported Q2 2026 EPS of $0.16, beating the $0.13 consensus by 23%, while total revenue of $296.8M declined | Aug 11, 2026 |
| BTQ | PRESS-RELEASE | neutral | 1/10 | BTQ Technologies Corp. announced it will host a conference call on August 14, 2026 to discuss its Q2 2026 results. | Aug 11, 2026 |
| PXLW | PRESS-RELEASE | neutral | 5/10 | No summary provided | Aug 11, 2026 |
| JKHY | PRESS-RELEASE | neutral | 2/10 | Jack Henry reported fiscal Q4 2026 deconversion revenue of $9.3M, bringing the full-year total to $42.8M. The press rele | Aug 11, 2026 |
| QUIK | PRESS-RELEASE | mixed | 6/10 | QuickLogic reported Q2 2026 revenue of $5.5M, up 48.7% YoY, but GAAP EPS of -$0.05 missed the consensus estimate of -$0. | Aug 11, 2026 |
| KYTX | PRESS-RELEASE | neutral | 5/10 | Kyverna Therapeutics reported Q2 2026 net loss of $0.63 per share, beating consensus of -$0.68 by 7.4%. The company high | Aug 11, 2026 |
| MAZE | PRESS-RELEASE | neutral | 4/10 | Maze Therapeutics reported Q2 2026 EPS of -$0.76, missing consensus of -$0.70 by 8.6%, with no license revenue for the q | Aug 11, 2026 |
| AQST | PRESS-RELEASE | neutral | 5/10 | Aquestive reported Q2 2026 revenue of $13.8M, beating the $11.6M consensus, but GAAP EPS of -$0.18 missed the -$0.12 con | Aug 11, 2026 |
| IZEA | PRESS-RELEASE | bearish | 6/10 | IZEA reported Q2 2026 revenue of $5.8M, down 36% YoY from $9.1M, and swung to a net loss of $0.7M from net income of $1. | Aug 11, 2026 |
| STXS | PRESS-RELEASE | mixed | 6/10 | Stereotaxis reported Q2 2026 revenue of $7.7M, missing consensus of $8.3M, and EPS of -$0.06, missing consensus of -$0.0 | Aug 11, 2026 |
| IKT | PRESS-RELEASE | neutral | 5/10 | Inhibikase Therapeutics reported Q2 2026 net loss of $0.11 per share, in line with the year-ago period but with a net lo | Aug 11, 2026 |
| ERAS | PRESS-RELEASE | neutral | 5/10 | No summary provided | Aug 11, 2026 |
| SLAB | PRESS-RELEASE | neutral | 5/10 | Silicon Labs reported Q2 2026 revenue of $228M (+18% YoY), beating consensus of $227.7M, but GAAP EPS was a loss of $(0. | Aug 11, 2026 |
| VINP | PRESS-RELEASE | bullish | 5/10 | Vinci Compass reported Q2 2026 Fee Related Earnings of R$88.7M (up 36% YoY) and announced the acquisition of Navi's Real | Aug 11, 2026 |
| WRAP | PRESS-RELEASE | bullish | 6/10 | Wrap Technologies reported Q2 2026 revenue of $2.1M (+103% YoY) and improved net loss to $(2.3M) from $(3.7M). The ATF d | Aug 11, 2026 |
| TSHA | PRESS-RELEASE | neutral | 5/10 | Taysha Gene Therapies reported Q2 2026 EPS of -$0.13, missing consensus of -$0.11 by 18.2%, with zero revenue vs. $1.99M | Aug 11, 2026 |
| XELB | PRESS-RELEASE | neutral | 1/10 | Xcel Brands, Inc announced it will host a conference call on August 14, 2026 to discuss its Q2 2026 results. | Aug 11, 2026 |
| NUAI | PRESS-RELEASE | bearish | 7/10 | New Era Energy & Digital reported a Q1 2026 EPS of -$0.16, significantly missing the consensus estimate of -$0.09 by 88. | Aug 11, 2026 |
| HII | PRESS-RELEASE | bullish | 6/10 | HII's Mission Technologies division won a $2.2 billion task order from U.S. Southern Command for advanced surveillance a | Aug 11, 2026 |
| ROP | PRESS-RELEASE | neutral | 3/10 | DAT Freight & Analytics, a Roper Technologies business unit, released its July 2026 Truckload Volume Index, reporting re | Aug 11, 2026 |
| CSPI | PRESS-RELEASE | neutral | 1/10 | CSP Inc. announced it will report its fiscal Q3 results on August 14, 2026. | Aug 11, 2026 |
| SAM | PRESS-RELEASE | neutral | 2/10 | Angry Orchard (brand of Boston Beer Company, NYSE: SAM) issued a marketing press release announcing a promotional stunt | Aug 11, 2026 |
| AMTB | PRESS-RELEASE | neutral | 1/10 | Amerant Bank announced a community fundraising campaign that raised over $100,000 for earthquake relief in Venezuela, wi | Aug 11, 2026 |
| EGAN | PRESS-RELEASE | neutral | 3/10 | eGain announced that Unigarant, a Dutch insurance company, selected its AI Knowledge Hub for knowledge management and en | Aug 11, 2026 |
| ACHV | PRESS-RELEASE | bearish | 7/10 | Achieve Life Sciences reported Q2 2026 EPS of -$0.80, significantly missing the consensus estimate of -$0.16, driven by | Aug 11, 2026 |
| NRXS | PRESS-RELEASE | mixed | 5/10 | NeurAxis reported Q2 2026 revenue of $1.9M (+116% YoY) and EPS of -$0.19 (40.6% beat vs -$0.32 consensus), driven by the | Aug 11, 2026 |
| FENC | PRESS-RELEASE | bullish | 6/10 | Fennec Pharmaceuticals reported Q2 2026 net product sales of $17.1M, up 78% YoY from $9.7M, and GAAP diluted EPS of $0.0 | Aug 11, 2026 |
| ECX | PRESS-RELEASE | mixed | 5/10 | ECARX reported Q2 2026 revenue of $225.2M (+45% YoY), beating the $226.6M consensus estimate by a slight margin. Net los | Aug 11, 2026 |
| CRNT | PRESS-RELEASE | mixed | 6/10 | Ceragon reported Q2 2026 revenue of $93.9M (+14.2% YoY), beating the $86.4M consensus, while non-GAAP EPS of $0.02 beat | Aug 11, 2026 |
| VOR | PRESS-RELEASE | neutral | 3/10 | Vor Bio reported Q2 2026 financial results with net loss of $62.8M, cash of $466.1M (plus $48.4M from July ATM sales), a | Aug 11, 2026 |